Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Nasolacrimal reflex pathway" is **not a molecule, receptor, or canonical therapeutic target**, but rather refers to the neural and physiological circuitry that mediates the reflexive production and drainage of tears. This pathway involves sensory input from the cornea and conjunctiva, which triggers increased tear production by the lacrimal gland via parasympathetic innervation[3][5]. Tears are then drained through the lacrimal apparatus—including puncta, canaliculi, lacrimal sac, and nasolacrimal duct—into the nasal cavity[1][7]. The nasolacrimal system as a whole maintains ocular surface health by lubricating and protecting it from desiccation or foreign bodies. Dysfunction in this reflex can contribute to dry eye disease or excessive tearing but does not represent a discrete molecular entity suitable for direct pharmacological targeting[2][4]. **Note:** There is something incorrect with this entry as it does not correspond to an individual molecule, protein, receptor, enzyme, transporter or other standard drug target class. Instead it describes an anatomical/physiological process involving multiple tissues and neural pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nasolacrimal reflex pathway.